Canada
  • About
    • Team
    • Partnerships
  • Products
    • Alvesco
    • Feraheme
    • Makena
    • Tudorza
    • All products
  • Patient Assistance Program
  • Medical Affairs
    • Request a MSL
    • Medical Information
    • IME Grants
    • ISR
  • Development
  • News
  • Careers
  • Contact

News release 2013

Covis Pharma to Acquire US Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®

April 4, 2013

News release

  • Contact Us
  • 2023
  • 2022
  • 2021
  • 2020
  • 2018
  • 2017
  • 2015
  • 2013
You are now leaving the covispharma.com website. / Vous allez quitter le site covispharma.com

Information on the covispharma.ca website is intended for solely the use of residents of Canada.

Les informations du site covispharma.ca sont destinées aux residents Canadiens.

 

Continue / Continuer Cancel / Annuler
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset